About 10 million people in the world die of malignant aliments. At the same time, in Europe more than 60000 women get ill of Ca PVU. With number of 1500 new cases of Ca PVU, Serbia occupies the first place in Europe. About 500 women die of this illness per a year. In about 10% of these cases, genetic factors cause the ailment. Individual behavior, environmental impact (habits, stress, and physical inactivity) increases the risk. Primary prevention of the malignant aliments includes eliminations of bed behavior and introduction of positive behavior.
The purpose of the work
The purpose of the work is the establishment of the total number and structure of malignancies, of female population living in the Municipality of Grocka for the 13-th period (2002-2014).
Methods
We used the documentation of the gynaecological departement for the period 2002-2014, it has been reported 347 malignant ailments of female population-2002-23, 2003-13, 2004-29, 2005-38, 2006-31, 2007-30, 2008-26, 2009-37, 2010-30, 2011-16, 2012-31, 2013-27, 2014-16.
By structure
Ca mammae-(C-50)-2002-19, 2003-9, 2004-21, 2005-31, 2006-21, 2007-21, 2008-25, 2009-27, 2010-21, 2011-12, 2012-4, 2013-4, 2014-1, Ca vulve(C 51)-2002-0, 2003-1; 2004-1,2005-1, 2006-1, 2009-2, 2010-0, 2011-0, 2012-0, 2013-0, 2014-1; Ca PVU(C53)-2002-5, 2003-3, 2004-7, 2005-6, 2007-9, 2008-1, 2010-9, 2011-4, 2012-16, 2013-9, 2014-8; Ca corporis uteri(C-54)-2002-3, 2003-4, 2004-6, 2005-4, 2006-4, 2007-6, 2008-9, 2009-5, 2010-7, 2011-4, 2012-11, 2013-14, 2014-5; Ca ovarii( C56)-2002-2, 2003-3, 2004-3, 2005-4, 2006-3, 2007-3, 2008-9, 2009-2, 2010-3, 2011-5, 2012-0, 2013-0, 2014-1.
The obligation of the introductuin that every women must pass the PAP test, colposcopy and the ultrasound examination once in a year, women older than 45 must pass mammography test and must continue with self-inspection, with the aid of media, will help to stop this negative trend, or at least to minimize it.1−3
None.
The author declares that there are no conflicts of interest.
© . This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.